Showing 1-10 of 15 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Novel mechanisms of ketoacidosis with SGLT2 inhibitors in type 1 diabetes | Regents of the University of Michigan | Jennifer Schaub | Improving Lives | 01-April-2025 to 31-March-2026 | $200.000,00 |
| Eye biorepository: A hub for the restoring vision moonshot | Regents of the University of Michigan | Patrice Fort | Improving Lives | 01-March-2025 to 28-February-2026 | $218.095,83 |
| Longitudinal non-inasive monitoring of vascular remodeling using oxygen-sensing nanoprobes | Regents of the University of Michigan | Maria Coronel | Cures | 01-March-2025 to 28-February-2030 | $1.000.000,00 |
| Identifying pharmaceuticals for enhancing metabolic maturity of stem cell derived islets | Regents of the University of Michigan | Lonnie Shea | Cures | 01-December-2024 to 30-November-2027 | $1.125.000,00 |
| University of Michigan and OHSU Breakthrough T1D Cardio-Renal Center of Excellence : Accelerating Breakthrough Targeted New Therapies for Cardio-Renal Complications for People with T1D | Regents of the University of Michigan | Matthias Kretzler | Improving Lives | 01-May-2025 to 30-April-2028 | $2.842.434,27 |
| GeLite: Glowing Engineered Luminescent Microgels for Transplant Evaluation | Regents of the University of Michigan | Maria Coronel | Cures | 01-June-2024 to 30-April-2026 | $200.000,00 |
| Orally Delivered Glucose-Responsive Insulin | Wayne State University | Zhiqiang Cao | Improving Lives | 01-June-2024 to 31-May-2026 | $274.499,13 |
| Sensor for early detection of immune activation in diabetes | Regents of the University of Michigan | Lonnie Shea | Cures | 01-January-2024 to 31-December-2025 | $300.000,00 |
| Cell capture scaffold to monitor islet transplant rejection | Regents of the University of Michigan | Lonnie Shea | Cures | 01-September-2023 to 28-February-2026 | $600.000,00 |
| Repurposing LRRK2 inhibitors for β cell protection in T1D | Regents of the University of Michigan | Scott Soleimanpour | Cures | 01-September-2023 to 31-August-2026 | $750.000,00 |